Evidence map›Paper›PMID 31327567›Full record

ArticleLancet (London, England)2019

Blood pressure control: a challenge to global health systems.

Clara K Chow, Rajeev Gupta

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05377203 (Initial Treatment With a Single Capsule Containing Quadruple Combination of Half Doses of Blood Pressure Medicines Versus Standard Dose Dual Therapy in Patients With Hypertension), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05377203 phase4completednot on this mapstarted 2022, after this paper: background citation

Initial Treatment With a Single Capsule Containing Quadruple Combination of Half Doses of Blood Pressure Medicines Versus Standard Dose Dual Therapy in Patients With Hypertension: A Single-center, Randomized, Double-blind, Crossover Trial

TypeinterventionalSponsorThe Third Xiangya Hospital of Central South UniversityRan2022 to 2023Enrolled90ConditionsHypertension, Arterial HypertensionArmsQuadruple combination of half doses therapy→Dual combination of standard dose therapy, Dual combination of standard dose therapy→ Quadruple combination of half doses therapy
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Recent studies on hypertension prevalence and control in India 2023.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Clara K ChowWestmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Department of Cardiology, Westmead Hospital, Sydney, NSW 2145, Australia. Electronic address: clara.chow@sydney.edu.au.
Rajeev GuptaAcademic Research Development Unit, Rajasthan University of Health Sciences, Jaipur, India; Department of Preventive Cardiology, Eternal Heart Care Centre & Research Institute, Jaipur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Global HealthHypertensionBlood PressureDeveloped CountriesHumansSurveys and Questionnaires

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.